Topic: EPA/DHA Omega-3 Fatty Acids for Health and the Prevention/Management of Chronic Disorders by Bruce Holub MD
End Pain - Dearborn, MI - September 26-28, 2014
Because of the reluctance of North Americans to consume fish/seafood on a regular basis, the average daily intake of the long-chain omega-3 fatty acids as docosahexaenoic acid (DHA) and eicosapentaenoic acid (EPA) is very low across all sectors of the population. There is evidence that increasing such intakes of DHA/EPA by higher intakes from fish/seafood or supplementation (‘nutraceuticals’) has been found to enhance various health outcomes throughout the life cycle as well as complementing the prevention/attenuation/management of various chronic disorders (cardiovascular, inflammatory, mental, selected malignancies, other ) and favorably modifying specific risk factors . These findings as published in leading peer-reviewed medical and nutritional journals have been supported by numerous epidemiological studies and randomized controlled trials. Recommended intakes of DHA/EPA for optimizing human health and the prevention/management of chronic disorders plus risk factor modification have been published by various national/international health, governmental, and medical organizations.
Down-loadable Zip file including MP3 audio file.
To listen to the first 5 minutes of the lecture use player below:
The lecture recording you are about to download is the property of ICIM and intended for your sole private use. Duplication or distribution in whole or in part, whether in print or electronically, is prohibited.
After checkout you will be given a link to download the lecture.